
    
      OUTLINE:

        -  Nonmyeloablative preparative regimen: Patients receive fludarabine phosphate IV over 1
           hour on days -6 to -2 and cyclophosphamide IV over 2 hours on day -6. Patients then
           undergo total-body irradiation on day -1. Some patients also receive anti-thymocyte
           globulin IV every 12 hours on days -6, -5, and -4.

        -  Umbilical cord blood (UCB) transplantation: Patients undergo unmanipulated UCB
           transplantation followed by complement 3a fragment primed UCB transplantation on day 0.

      Treatment for graft-vs-host disease prophylaxis is also given.

      After completion of study therapy, patients are followed up periodically for up to 2 years.
    
  